Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.55
-0.0400-2.52%
Post-market: 1.550.00000.00%18:58 EDT
Volume:13.17K
Turnover:20.44K
Market Cap:15.77M
PE:-0.99
High:1.62
Open:1.55
Low:1.50
Close:1.59
Loading ...
Mar 04, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Mar 04, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 03, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 28, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 24, 2020

Major Issues Report

Current report, item 1.01
Feb 18, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Jan 29, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Dec 16, 2019

Major Issues Report

Current report, item 3.01
Nov 22, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, item 8.01
Oct 31, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 30, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 30, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]